The Digital Medicine Society (DiMe) announced a collaboration with Peterson Health Technology Institute (PHTI), ZS Associates and other industry groups to improve the development and implementation of integrated evidence plans (IEPs) for digital health products.
The goal of the collaboration is to align best practices pertaining to streamlining the path to commercialization for digital health...
The Digital Medicine Society (DiMe) and a suite of digital health and pharma players partnered to launch a toolkit aimed at improving diversity, equity and inclusion in clinical trials.
The resources include a guide to each step of a digital clinical trial, shared definitions of terms like "diversity" and "equity," a list of different digital tools that could be used and the potential benefits...
The Digital Medicine Society (DiMe) on Monday revealed four toolkits to help healthcare and life science organizations use data from sensors like wearables and remote patient monitoring systems at scale.
The four toolkits are based on resources derived from the society's Sensor Data Integrations project, which includes organizations like Amazon Web Services, Oracle, the Moffitt Cancer Center,...
The Digital Medicine Society (DiMe) teamed up with a slew of pharma giants and payers to launch a digital endpoints toolkit for stakeholders.
The open-access toolkit, which came from a partnership between DiMe, Anthem, Biogen, Eli Lilly, Evidation, Janssen, Merck, Pfizer and Savvy Co-op, gives payers a road map for including digital endpoints in reimbursement for new drugs. Dubbed the 3Ps toolkit...
Bia Care teams with Imperial College to tackle women’s health inequalities
Digital menopause health start-up Bia Care is taking part in a randomised control trial which aims to tackle women’s health inequalities.
The research, in partnership with Imperial College London, brings together the work of national thought leaders on menopause inequalities, and builds on the work of social campaigners...
